Mayo Clinic Laboratories > Therapeutics

Discover the differences

Therapeutics testing covers a wide range of areas from controlled substance monitoring to pharmacogenomics (PGx). Our testing delivers clarity on drug use to advance understanding and improve patient outcomes. We provide access to Mayo Clinic experts and a test menu developed through evidence-driven clinical innovation to help clinicians guide patient care.

Answers From the Lab Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug
Webinar When is it Cool to Drool? Oral Fluid Testing for Controlled Substance Monitoring
Answers From the Lab Oral fluid offers an alternative specimen for controlled substance monitoring
Hot Topic High-Resolution Targeted Benzodiazepine Screen
Answers From the Lab Accurately Characterize Marijuana Use Through Urine THC Testing

Therapeutics Testing services

Addiction rehabilitation monitoring Addiction rehabilitation monitoring
Addiction rehabilitation monitoring

Our approach to comprehensive drug testing for individuals in need of addiction rehabilitation testing aligns with the American Society of Addiction Medicine’s national consensus statement recommending drug testing to identify the presence of prescribed and approved medication taken as part of addiction recovery therapy, as well as illicit substances most commonly abused.

Biopharma testing Biopharma testing
Biopharma testing

Our robust therapeutics portfolio includes controlled substance monitoring and addiction rehabilitation profiles as well as leading-edge alcohol biomarker testing. This testing was developed through evidence-driven innovation and designed to deliver clarity on drug and alcohol use.

Clinical and forensic toxicology Clinical and forensic toxicology
Clinical and forensic toxicology

The Clinical and Forensic Toxicology Laboratory, Clinical Mass Spectrometry Laboratory, and Clinical Mass Spectrometry Development Laboratory at Mayo Clinic develop, implement, and perform clinical, forensic, and emergency toxicology testing on urine, serum, and meconium specimens received from Mayo Clinic, our regional practice, and clients around the world.

Controlled substance monitoring Controlled substance monitoring
Controlled substance monitoring

We offer the industry’s most comprehensive, evidence-based drug testing menu, which was developed with consistency to practice guidelines to help clinicians identify specific prescription drugs, adulterants, and illicit substances.

Drug class testing Drug class testing
Drug class testing

Therapeutics testing covers a wide range of areas, from controlled substance monitoring to pharmacogenomics (PGx). Our testing delivers clarity on drug use to advance understanding and improve patient outcomes. We provide access to Mayo Clinic experts and a test menu developed through evidence-driven clinical innovation to help clinicians guide patient care.

Pharmacogenomic testing Pharmacogenomic testing
Pharmacogenomic testing

Featuring comprehensive panels and single gene testing, Mayo Clinic Laboratories’ PGx testing provides physicians with a deeper understanding of their patients’ genetic makeup to help personalize dosing decisions across an array of conditions.

Precision therapeutics Precision therapeutics
Precision therapeutics

Precision therapeutics, or the use of PGx testing in conjunction with therapeutic drug monitoring (TDM), has the potential to revolutionize medication selection and prescription monitoring. Our TDM and PGx evaluations increase understanding of an individual’s genetic makeup and personalize dosing decisions.

Therapeutic drug monitoring Therapeutic drug monitoring
Therapeutic drug monitoring

Our comprehensive therapeutic drug monitoring (TDM) test menu covers more than 70 drugs across psychiatry, neurology, transplant medicine, oncology, and other clinical disciplines, ensuring accurate, personalized care through advanced analysis and innovation.

“The goal is not to identify every drug technically possible, but to perform medically necessary testing for those drugs that are most likely to impact clinical outcomes.”

Paul Jannetto, Ph.D., Director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab

Our difference

Evidence-based testing
Our robust, evidence-based test menu includes hundreds of assays to identify and monitor both prescribed and illicit drug use. Propelled by ongoing research, we’re continually innovating to find better ways to provide answers, giving you and your patients access to the most cutting-edge testing and technologies.

Individualized insights
Our clinically driven, algorithmic approach to testing ensures the right patient receives the right test at the right time. This eliminates unnecessary testing, speeds up test results, reduces the total cost of care, and improves patient experiences.

Access to expertise
When you partner with Mayo Clinic Laboratories, you extend your network to include some of the world’s leading experts. Mayo Clinic clinicians, laboratorians, and genetic counselors are available to discuss testing options, interpret results, or help with case review and coordination.

News and updates

The latest

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP

Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in survival of the transplanted organ.

Learn more

No posts available.

Resources
Download Therapeutics test request form
Delivering specialized testing and consultative support for:
Learn more Commercial laboratories
Learn more Global healthcare
Learn more Hospitals and health systems

LEARN MORE ABOUT HOW WE CAN BUILD YOUR LAB'S POTENTIAL.

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

Are you a patient? Click here.